Coherence Neuro

Coherence Neuro

HealthNeurotechnologyB2B📍 United States

Coherence Neuro is developing brain implants to treat cancer, specifically glioblastoma. Their leading product, SOMA, is a button-sized implant that monitors and disrupts tumor development using electrical signals. This Series A funding will enable their first chronic human trial for glioblastoma treatment and expansion to other conditions.

Total raised
Undisclosed
tracked to date
Latest round
Series A
Oct 23, 2026
Known investors
5
led by Founders Fund

Is this your company?

Claim this profile to get matched with investors who fund Health startups in United States.

Claim this profile →

🏆 Featured in Datapile’s Q4 2026 USA Funding Report

Read the Q4 2026 USA report →
Add this badge to your site
<a href="https://datapile.co/reports/q4-2026-usa-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q4 2026 USA Funding Report</a>

Funding history

  1. 1
    $45 MillionSeries AOct 23, 2026

    Led by Founders Fund

    Announcement ↗

Founder

Elise Jenkins
Elise Jenkins

Investors in Coherence Neuro

Backers from this company's tracked funding rounds.

  • FFounders FundLead investorVC firm
  • OOpenAI Startup FundVC firm
  • LLux CapitalVC firm
  • OOlive CapitalVC firm
  • 88VCVC firm

Coherence Neuro in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile